Study of A3309 in Patients With Dyslipidemia

NCT01069783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: A3309
DRUG: A3309
DRUG: Placebo

Sponsor

Albireo